Provectus presents data from PV-10 Phase 2 study at 2011 International Melanoma Congr

[News]

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that data and study design features on PV-10 for metastatic melanoma were presented at the 2011 International Melanoma Congress on November 12, 2011, during the 5th Meeting of Interdisciplinary Melanoma/Skin Cancer Centres meeting, in Tampa, Florida.

More... (http://www.news-medical.net/news/20111114/Provectus-presents-data-from-PV-10-Phase-2-study-at-2011-International-Melanoma-Congress.aspx)